Figure 2From: Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trialsSchematic diagram of study designs. *No washout was performed in the studies adding linagliptin to existing treatment with metformin or sulfonylurea or both. Complementary study designs allowed pooling of the data.Back to article page